DOC stock icon

Healthpeak Properties

20.86 USD
-0.39
1.84%
At close Nov 15, 4:00 PM EST
After hours
20.86
+0.00
0.00%
1 day
-1.84%
5 days
-8.35%
1 month
-6.54%
3 months
-3.34%
6 months
3.01%
Year to date
4.14%
1 year
23.07%
5 years
-39.45%
10 years
-52.77%
 

About: Healthpeak owns a diversified healthcare portfolio of approximately 672 in-place properties spread across mainly medical office and life science assets, plus a handful of senior housing, hospital, and skilled nursing/post-acute care assets, as well.

Employees: 193

0
Funds holding %
of 6,704 funds
0
Analysts bullish %
of 8 analysts

Fund manager confidence

Based on 2024 Q3 regulatory filings by fund managers ($100M+ AUM)

505% more call options, than puts

Call options by funds: $18.6M | Put options by funds: $3.06M

29% more funds holding in top 10

Funds holding in top 10: 7 [Q2] → 9 (+2) [Q3]

13% more first-time investments, than exits

New positions opened: 103 | Existing positions closed: 91

13% more capital invested

Capital invested by funds: $12.8B [Q2] → $14.4B (+$1.64B) [Q3]

2% more funds holding

Funds holding: 695 [Q2] → 707 (+12) [Q3]

6% more repeat investments, than reductions

Existing positions increased: 262 | Existing positions reduced: 247

2.24% less ownership

Funds ownership: 92.83% [Q2] → 90.59% (-2.24%) [Q3]

Research analyst outlook

8 Wall Street Analysts provided 1 year price targets over the past 3 months

Low target
$22
5%
upside
Avg. target
$25
19%
upside
High target
$28
34%
upside

8 analyst ratings

positive
75%
neutral
25%
negative
0%
RBC Capital
Michael Carroll
57% 1-year accuracy
12 / 21 met price target
25%upside
$26
Outperform
Maintained
4 Nov 2024
Baird
Amanda Sweitzer
0 / 0 met price target
20%upside
$25
Outperform
Maintained
30 Oct 2024
Deutsche Bank
Omotayo Okusanya
72% 1-year accuracy
13 / 18 met price target
34%upside
$28
Buy
Upgraded
21 Oct 2024
Wells Fargo
Connor Siversky
78% 1-year accuracy
7 / 9 met price target
10%upside
$23
Equal-Weight
Assumed
1 Oct 2024
Evercore ISI Group
James Kammert
50% 1-year accuracy
1 / 2 met price target
25%upside
$26
Outperform
Maintained
16 Sept 2024

Financial journalist opinion

Based on 29 articles about DOC published over the past 30 days

Charts implemented using Lightweight Charts™